Testimony Concerning Etoricoxib (Arcoxia) - Public Citizen
Indirect comparison of NSAIDs for ankylosing spondylitis: Network meta‑analysis of randomized, double‑blinded, controlled trials
Update on the clinical pharmacology of etoricoxib, a potent cyclooxygenase-2 inhibitor | Semantic Scholar
Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II) | Annals of the Rheumatic Diseases
Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials | SpringerLink
Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library
Topical Diclofenac, an Efficacious Treatment for Osteoarthritis: A Narrative Review | Rheumatology and Therapy
Effect of administration of ketorolac, etoricoxib or diclofenac in the... | Download Scientific Diagram
A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis - ScienceDirect
Probability that each treatment provides the greatest improvements in... | Download Scientific Diagram
Heart Failure Factors in Patients on Etoricoxib or Diclofenac
Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis | The BMJ
Testimony Concerning Etoricoxib (Arcoxia) - Public Citizen
Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis | Arthritis Research & Therapy | Full ...
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - ScienceDirect
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II) | Annals of the Rheumatic Diseases
Effects of multiple dosing of etoricoxib, diclofenac, or indomethacin... | Download Scientific Diagram
Etoricoxib | SpringerLink
A Randomized Double-Blind Comparative Study of Efficacy and Safety Between Low-Dose Etoricoxib and Ibuprofen Coadministered with Low-Dose Paracetamol for Dental Pain - Kothari Saroj, Bansal Haresh, Paharia Yogendra, 2022
Nonsteroidal Anti-imflamitory Drugs:New Perspectives on Old Medications - BroadcastMed
Testimony Concerning Etoricoxib (Arcoxia) - Public Citizen
Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library
Etoricoxib - an overview | ScienceDirect Topics
Testimony Concerning Etoricoxib (Arcoxia) - Public Citizen
